Clincosm LogoSign in Get a demo

Screening for Memory Studies

Sponsor
John Wesson Ashford Jr (U.S. Fed)
Overall Status
Active, not recruiting
CT.gov ID
NCT01123018
Collaborator
US Department of Veterans Affairs (U.S. Fed)
2,000
Enrollment
1
Location
270
Duration (Months)
7.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

We hope to recruit participants into various clinical trials and research projects.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Memtrax Memory screening test

Detailed Description

The purpose of this protocol is to advertise, recruit, and do a preliminary screen for various clinical trials. Anonymous information collected will be entered in a database available to researchers connected with the Stanford/VA Aging Clinical Research Center, located at VA Palo Alto Health Care System, Palo Alto Division.

Study Design

Study Type:
Observational
Anticipated Enrollment :
2000 participants
Observational Model:
Ecologic or Community
Time Perspective:
Other
Official Title:
Screening for Memory Studies
Study Start Date :
Jun 1, 2007
Anticipated Primary Completion Date :
Dec 1, 2029
Anticipated Study Completion Date :
Dec 1, 2029

Arms and Interventions

Arm Intervention/Treatment
Older Adults

Persons over age 60 Participants will complete the Memtrax memory screening test

Behavioral: Memtrax Memory screening test
Memory Screening test
Other Names:
  • Memory screening

    		•

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      55 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      Yes
      Inclusion Criteria:
      • Age 55 or over.
      Exclusion Criteria:

      • Major psychiatric problems.

      • Major medical problems.

      • Aversion to test-taking.

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 VA Palo Alto Health Care System Palo Alto California United States 94304

      Sponsors and Collaborators

      • John Wesson Ashford Jr
      • US Department of Veterans Affairs

      Investigators

      • Principal Investigator: J. Wesson Ashford Jr., MD, PhD, Stanford University

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      John Wesson Ashford Jr, Director, VA Palo Alto Health Care System
      ClinicalTrials.gov Identifier:
      NCT01123018
      Other Study ID Numbers:
      • SU-06302009-2900
      First Posted:
      May 13, 2010
      Last Update Posted:
      Apr 27, 2022
      Last Verified:
      Apr 1, 2022
      Individual Participant Data (IPD) Sharing Statement:
      Undecided
      Plan to Share IPD:
      Undecided
      Keywords provided by John Wesson Ashford Jr, Director, VA Palo Alto Health Care System
      Memory Loss
      Additional relevant MeSH terms:
      Memory Disorders
      Amnesia

      Study Results

      No Results Posted as of Apr 27, 2022